- Home
- Publications
- Publication Search
- Publication Details
Title
Distinct Roles of mTOR Targets S6K1 and S6K2 in Breast Cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 4, Pages 1199
Publisher
MDPI AG
Online
2020-02-11
DOI
10.3390/ijms21041199
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression of miRNAs Targeting mTOR and S6K1 Genes of mTOR Signaling Pathway Including miR-96, miR-557, and miR-3182 in Triple-Negative Breast Cancer
- (2018) Javad Razaviyan et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- The estrogen-related receptors in metabolism and cancer: newer insights
- (2018) Harmit S. Ranhotra JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- miR‑1273g‑3p promotes proliferation, migration and invasion of LoVo cells via cannabinoid receptor 1 through activation of ERBB4/PIK3R3/mTOR/S6K2 signaling pathway
- (2018) Min Li et al. Molecular Medicine Reports
- The p85 isoform of the kinase S6K1 functions as a secreted oncoprotein to facilitate cell migration and tumor growth
- (2018) Jianjun Zhang et al. Science Signaling
- The p85 isoform of the kinase S6K1 functions as a secreted oncoprotein to facilitate cell migration and tumor growth
- (2018) Jianjun Zhang et al. Science Signaling
- S6K2 promises an important therapeutic potential for cancer
- (2018) Nurettin İlter Sever et al. Future Oncology
- PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trials
- (2017) Nandini Dey et al. PHARMACOLOGY & THERAPEUTICS
- Targeting the mTOR pathway in breast cancer
- (2017) Jia Liu et al. TUMOR BIOLOGY
- Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K/Akt/mTOR in estrogen receptor-positive, HER2-negative breast cancer
- (2017) Kazuhiro Araki et al. Breast Cancer
- Regulation of anti-apoptotic Bcl-2 family protein Mcl-1 by S6 kinase 2
- (2017) Alakananda Basu et al. PLoS One
- PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment
- (2016) Angel Guerrero-Zotano et al. CANCER AND METASTASIS REVIEWS
- ERR Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer
- (2015) S. Manna et al. CLINICAL CANCER RESEARCH
- S6 kinase signaling: tamoxifen response and prognostic indication in two breast cancer cohorts
- (2015) J. Bostner et al. ENDOCRINE-RELATED CANCER
- The S6K protein family in health and disease
- (2015) Mariana R. Tavares et al. LIFE SCIENCES
- Immunohistochemical analysis of phosphorylated mammalian target of rapamycin and its downstream signaling components in invasive breast cancer
- (2015) BIN-LIN MA et al. Molecular Medicine Reports
- PI3K/mTOR mediate mitogen-dependent HDAC1 phosphorylation in breast cancer: a novel regulation of estrogen receptor expression
- (2015) Simona Citro et al. Journal of Molecular Cell Biology
- S6K1 inhibition enhances the apoptotic cell death of breast cancer cells in response to Bcl-2/Bcl-xL inhibition by the downregulation of survivin
- (2015) JIN-AH PARK et al. Oncology Letters
- Revealing Different Roles of the mTOR-Targets S6K1 and S6K2 in Breast Cancer by Expression Profiling and Structural Analysis
- (2015) Elin Karlsson et al. PLoS One
- Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2†
- (2014) M. Piccart et al. ANNALS OF ONCOLOGY
- A phase I trial of LY2584702 tosylate, a p70 S6 kinase inhibitor, in patients with advanced solid tumours
- (2014) Anthony Tolcher et al. EUROPEAN JOURNAL OF CANCER
- A phase Ib trial of LY2584702 tosylate, a p70 S6 inhibitor, in combination with erlotinib or everolimus in patients with solid tumours
- (2014) Antoine Hollebecque et al. EUROPEAN JOURNAL OF CANCER
- miR-15/16 complex targets p70S6 kinase1 and controls cell proliferation in MDA-MB-231 breast cancer cells
- (2014) M. Janaki Ramaiah et al. GENE
- MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway
- (2014) T Yu et al. ONCOGENE
- Inhibition of S6K1 enhances glucose deprivation-induced cell death via downregulation of anti-apoptotic proteins in MCF-7 breast cancer cells
- (2013) Ha-Na Choi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- S6K1 inhibition enhances tamoxifen-induced cell death in MCF-7 cells through translational inhibition of Mcl-1 and survivin
- (2013) Sung-Eun Hong et al. CELL BIOLOGY AND TOXICOLOGY
- Identification of the general transcription factor Yin Yang 1 as a novel and specific binding partner for S6 Kinase 2
- (2013) Heba M.S. Ismail et al. CELLULAR SIGNALLING
- Derailed Estrogen Signaling and Breast Cancer: An Authentic Couple
- (2013) Bramanandam Manavathi et al. ENDOCRINE REVIEWS
- S6 Kinase 2 Is Bound to Chromatin-Nuclear Matrix Cellular Fractions and Is Able to Phosphorylate Histone H3 at Threonine 45 In Vitro and In Vivo
- (2013) Heba M.S. Ismail et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- S6K2: The Neglected S6 Kinase Family Member
- (2013) Olivier E. Pardo et al. Frontiers in Oncology
- The role of S6K1 in ER-positive breast cancer
- (2012) Marina K. Holz CELL CYCLE
- Targeting mTOR Pathways in Human Malignancies
- (2012) Angelica Fasolo et al. CURRENT PHARMACEUTICAL DESIGN
- 11q13 is a susceptibility locus for hormone receptor positive breast cancer
- (2012) Diether Lambrechts et al. HUMAN MUTATION
- Tumor Suppressor PDCD4 Represses Internal Ribosome Entry Site-Mediated Translation of Antiapoptotic Proteins and Is Regulated by S6 Kinase 2
- (2012) U. Liwak et al. MOLECULAR AND CELLULAR BIOLOGY
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- Estrogenic regulation of S6K1 expression creates a positive regulatory loop in control of breast cancer cell proliferation
- (2012) D M Maruani et al. ONCOGENE
- S6K1 Alternative Splicing Modulates Its Oncogenic Activity and Regulates mTORC1
- (2012) Vered Ben-Hur et al. Cell Reports
- S6 Kinase 2 Promotes Breast Cancer Cell Survival via Akt
- (2011) S. Sridharan et al. CANCER RESEARCH
- Differential Expression of S6K2 Dictates Tissue-Specific Requirement for S6K1 in Mediating Aberrant mTORC1 Signaling and Tumorigenesis
- (2011) C. Nardella et al. CANCER RESEARCH
- High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1
- (2011) Elin Karlsson et al. GENES CHROMOSOMES & CANCER
- PHLPP-Mediated Dephosphorylation of S6K1 Inhibits Protein Translation and Cell Growth
- (2011) J. Liu et al. MOLECULAR AND CELLULAR BIOLOGY
- The IGF Pathway Regulates ERα through a S6K1-Dependent Mechanism in Breast Cancer Cells
- (2011) Marc A. Becker et al. MOLECULAR ENDOCRINOLOGY
- Nucleocytoplasmic localization of p70 S6K1, but not of its isoforms p85 and p31, is regulated by TSC2/mTOR
- (2011) M Rosner et al. ONCOGENE
- Targeting the Phosphatidylinositol 3-Kinase Signaling Pathway in Breast Cancer
- (2011) L. F. Hernandez-Aya et al. ONCOLOGIST
- Phosphoproteomic Analysis Identifies Grb10 as an mTORC1 Substrate That Negatively Regulates Insulin Signaling
- (2011) Y. Yu et al. SCIENCE
- The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling
- (2011) P. P. Hsu et al. SCIENCE
- Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1)
- (2010) Laura R. Pearce et al. BIOCHEMICAL JOURNAL
- Phosphorylated S6K1 is a possible marker for endocrine therapy resistance in hormone receptor-positive breast cancer
- (2010) Eun-Kyu Kim et al. BREAST CANCER RESEARCH AND TREATMENT
- Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer
- (2010) Gizeh Pérez-Tenorio et al. BREAST CANCER RESEARCH AND TREATMENT
- The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer
- (2010) Carlos A. Castaneda et al. CANCER AND METASTASIS REVIEWS
- Distinct Biological Roles for the Akt Family in Mammary Tumor Progression: Figure 1.
- (2010) Rachelle L. Dillon et al. CANCER RESEARCH
- S6K1 is a multifaceted regulator of Mdm2 that connects nutrient status and DNA damage response
- (2010) Keng Po Lai et al. EMBO JOURNAL
- Functions and regulation of the 70kDa ribosomal S6 kinases
- (2010) Tim R. Fenton et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Tuberous sclerosis complex: tumors and tumorigenesis
- (2010) Julita Borkowska et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Involvement of Heterogeneous Ribonucleoprotein F in the Regulation of Cell Proliferation via the Mammalian Target of Rapamycin/S6 Kinase 2 Pathway
- (2010) Eddy T. H. Goh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- mTOR-Dependent Regulation of PHLPP Expression Controls the Rapamycin Sensitivity in Cancer Cells
- (2010) Jianyu Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Management of breast cancer with targeted agents: importance of heterogenicity
- (2010) Serena Di Cosimo et al. Nature Reviews Clinical Oncology
- Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis
- (2010) Shijie Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted therapy of metastatic breast cancer
- (2009) Alfonso Sánchez-Muñoz et al. Clinical & Translational Oncology
- Histone acetyltransferases interact with and acetylate p70 ribosomal S6 kinases in vitro and in vivo
- (2009) T.R. Fenton et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- IKKϵ Phosphorylation of Estrogen Receptor α Ser-167 and Contribution to Tamoxifen Resistance in Breast Cancer
- (2009) Jian-Ping Guo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Characterization of Rictor Phosphorylation Sites Reveals Direct Regulation of mTOR Complex 2 by S6K1
- (2009) C. C. Dibble et al. MOLECULAR AND CELLULAR BIOLOGY
- mTORC1-Activated S6K1 Phosphorylates Rictor on Threonine 1135 and Regulates mTORC2 Signaling
- (2009) L.-A. Julien et al. MOLECULAR AND CELLULAR BIOLOGY
- Rictor is a novel target of p70 S6 kinase-1
- (2009) C Treins et al. ONCOGENE
- Mice Deficient in Ribosomal Protein S6 Phosphorylation Suffer from Muscle Weakness that Reflects a Growth Defect and Energy Deficit
- (2009) Igor Ruvinsky et al. PLoS One
- Inhibitors of the PI3K/Akt/mTOR Pathway: New Hope for Breast Cancer Patients
- (2009) Sandra Ghayad et al. Recent Patents on Anti-Cancer Drug Discovery
- Regulation of ribosomal protein S6 kinases by ubiquitination
- (2008) Mong-Lien Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Enhancing Mammalian Target of Rapamycin (mTOR)-Targeted Cancer Therapy by Preventing mTOR/Raptor Inhibition-Initiated, mTOR/Rictor-Independent Akt Activation
- (2008) X. Wang et al. CANCER RESEARCH
- The ubiquitination of ribosomal S6 kinases is independent from the mitogen-induced phosphorylation/activation of the kinase
- (2008) J. Gwalter et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- S6 Kinase 1 Regulates Estrogen Receptor α in Control of Breast Cancer Cell Proliferation
- (2008) Rachel L. Yamnik et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- S6K Directly Phosphorylates IRS-1 on Ser-270 to Promote Insulin Resistance in Response to TNF-α Signaling through IKK2
- (2008) Jin Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer
- (2008) Arkaitz Carracedo et al. JOURNAL OF CLINICAL INVESTIGATION
- The RSK family of kinases: emerging roles in cellular signalling
- (2008) Rana Anjum et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now